Radiopharm Theranostics has appointed Rama Abu Shmeis as Senior Vice President Chemistry, Manufacturing and Controls, or “CMC” as the latest in a line of top-shelf appointments. The ASX-listed cancer fighter says Dr Shmeis brings a 23-year record of achievements in leading strategic, operational and scientific aspects of CMC development and manufacturing that also covers a wide variety of dose forms, products and technologies.